We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
It commonly happens in stock investing that investors miss the chance of buying winning stocks that they knew would stand out. Before they take the plunge, others get to know the hidden potential and enter into these stocks, pushing them out of reach.
So, instead of repenting, spotting the off-the-radar potential winners and immediately investing in them could be a smart decision.
One such company that looks well positioned for a solid gain, but has been overlooked by investors lately, is CNOOC Limited (CEO - Free Report) . This Oil and Gas - Integrated - Emerging Markets stock has actually seen estimates rise over the past month for the current fiscal year by about 22.3%. But that is not yet reflected in its price, as the stock gained only 1.2% over the same time frame.
You should not be concerned about the price remaining muted going forward. This year’s significant earnings growth expectation over the prior year should ultimately translate into price appreciation.
So if you are looking for a stock flying under-the-radar that is well-equipped to bounce down the road, make sure to consider CNOOC. Solid estimate revisions and an impressive Zacks Rank suggest that better days may be ahead for CEO and that now might be an interesting buying opportunity.
5 Medical Stocks to Buy Now
Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.
New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.
Image: Bigstock
Should CNOOC (CEO) Be On Your Radar Now?
It commonly happens in stock investing that investors miss the chance of buying winning stocks that they knew would stand out. Before they take the plunge, others get to know the hidden potential and enter into these stocks, pushing them out of reach.
So, instead of repenting, spotting the off-the-radar potential winners and immediately investing in them could be a smart decision.
One such company that looks well positioned for a solid gain, but has been overlooked by investors lately, is CNOOC Limited (CEO - Free Report) . This Oil and Gas - Integrated - Emerging Markets stock has actually seen estimates rise over the past month for the current fiscal year by about 22.3%. But that is not yet reflected in its price, as the stock gained only 1.2% over the same time frame.
CNOOC Limited Price and Consensus
CNOOC Limited Price and Consensus | CNOOC Limited Quote
You should not be concerned about the price remaining muted going forward. This year’s significant earnings growth expectation over the prior year should ultimately translate into price appreciation.
And if this isn’t enough, CEO currently carries a Zacks Rank #1 (Strong Buy) which further underscores the potential for its outperformance (See the performance of Zacks' portfolios and strategies here: About Zacks Performance).You can see the complete list of today’s Zacks #1 Rank stocks here.
So if you are looking for a stock flying under-the-radar that is well-equipped to bounce down the road, make sure to consider CNOOC. Solid estimate revisions and an impressive Zacks Rank suggest that better days may be ahead for CEO and that now might be an interesting buying opportunity.
5 Medical Stocks to Buy Now
Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.
New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.
Click here to see the 5 stocks >>